Principal Financial Group Inc Protagonist Therapeutics, Inc Transaction History

Principal Financial Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$24.66 - $34.8 $107,049 - $151,066	-4,341 Reduced 30.21%	10,028 $347,000
Q1 2024 Apr 29, 2024	SELL	$21.79 - $32.15 $1,307 - $1,929	-60 Reduced 0.42%	14,369 $415,000
Q4 2023 Feb 07, 2024	SELL	$14.05 - $23.44 $7,615 - $12,704	-542 Reduced 3.62%	14,429 $330,000
Q3 2023 Nov 02, 2023	BUY	$16.68 - $23.66 $17,814 - $25,268	1,068 Added 7.68%	14,971 $249,000
Q2 2023 Aug 07, 2023	BUY	$18.02 - $29.36 $6,847 - $11,156	380 Added 2.81%	13,903 $384,000
Q1 2023 May 09, 2023	BUY	$10.78 - $25.38 $19,242 - $45,303	1,785 Added 15.21%	13,523 $311,000
Q4 2022 Feb 09, 2023	BUY	$7.36 - $11.17 $10,223 - $15,515	1,389 Added 13.42%	11,738 $128,000
Q3 2022 Nov 09, 2022	BUY	$7.86 - $11.71 $81,343 - $121,186	10,349 New	10,349 $87,000
Q1 2022 May 09, 2022	SELL	$23.34 - $36.08 $177,547 - $274,460	-7,607 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$17.63 - $37.1 $134,111 - $282,219	7,607 New	7,607 $260,000
Q3 2021 Nov 09, 2021	SELL	$12.95 - $49.69 $214,193 - $821,872	-16,540 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$25.57 - $44.88 $213,867 - $375,376	8,364 Added 102.3%	16,540 $742,000
Q1 2021 May 10, 2021	BUY	$19.02 - $31.15 $155,507 - $254,682	8,176 New	8,176 $212,000

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.